Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The real-life experience with cardiovascular complications in the first dose of fingolimod for multiple sclerosis.
Immune responses in rapidly progressive dementia: a comparative study of neuroinflammatory markers in Creutzfeldt-Jakob disease, Alzheimer¿s disease and multiple sclerosis.
Does the patient know best? Quality of life assessment in multiple sclerosis trials.
Bispecificity for Myelin and Neuronal Self-Antigens Is a Common Feature of CD4 T Cells in C57BL/6 Mice.
Clinical application of susceptibility weighted imaging: exploring from routine service.
[2011: What's new in dysimmune neuropathies.]
Assessing interactions between HLA-DRB1*15 and infectious mononucleosis on the risk of multiple sclerosis.
Postpartum complicated by transverse myelitis.
[Differential diagnosis between multiple sclerosis and neurological presentations of HIV-infection: a literature review and a case report].
Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets.
Robert Whytt, Benjamin Franklin, and the first probable case of multiple sclerosis.
Neuropathic pruritus (itch) in neuromyelitis optica.
Neutralizing Antibodies Are Associated with a Reduction of Interferon-β Efficacy during the Treatment of Japanese Multiple Sclerosis Patients.
Optical coherence tomography and its use in optical neuritis and multiple sclerosis.
Case Studies: LAAM, Naltrexone, Clozapine, and Nicorette
Catastrophic brain relapse in seronegative NMO after a single dose of natalizumab.
A Clinical Study Using MEDI-551 in Adult Subjects With Relapsed or Refractory Advanced B-Cell Malignancies
The Opioid System and Brain Development: Effects of Methadone on the Oligodendrocyte Lineage and the Early Stages of Myelination.
Crossfit training changes brain-derived neurotrophic factor and irisin levels at rest, after wingate and progressive tests, and improves aerobic capacity and body composition of young physically active men and women.
Optical Coherence Tomography Detection of Neurodegeneration in Multiple Sclerosis.
Perforin Expression by CD4+ Regulatory T Cells Increases at Multiple Sclerosis Relapse: Sex Differences.
Unemployment in multiple sclerosis (MS): utility of the MS Functional Composite and cognitive testing.
Long-term safety and efficacy of dalfampridine for walking impairment in patients with multiple sclerosis: Results of open-label extensions of two Phase 3 clinical trials.
Cerebrospinal fluid analysis.
Reduced R2' in multiple sclerosis normal appearing white matter and lesions may reflect decreased myelin and iron content.
Pages
« first
‹ previous
…
236
237
238
239
240
241
242
243
244
…
next ›
last »